 Home > Medical News > Latest Medical News > Hutchison Whampoa third-generation BTK inhibitor approved for clinical treatment of B-cell non-Hodgkin's lymphoma

Hutchison Whampoa third-generation BTK inhibitor approved for clinical treatment of B-cell non-Hodgkin's lymphoma

 Last Update: 2021-09-30
 Source: Internet
 Author: User

Tags

treatment

drug interaction website

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

Author: Sunshine

On September 23, the CDE official website showed that the Hutchison Whampoa HMPL-760 capsule clinical trial application was approved by the Food and Drug Administration for the treatment of B-cell non-Hodgkin's lymphoma

HMPL-760 is a research, highly selective, third-generation small molecule BTK (Bruton's tyrosine protein kinase) inhibitor that is more effective than the first-generation BTK inhibitor.

BTK is an important signal molecule in the B cell receptor pathway.

At present, five BTK inhibitors have been approved for the market worldwide, namely ibrutinib, AstraZeneca's acatinib, zebutinib, tirabrutinib, and abutinib

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Hutchison Whampoa third-generation BTK inhibitor approved for clinical treatment of B-cell non-Hodgkin's lymphoma​

Hutchison Whampoa third-generation BTK inhibitor approved for clinical treatment of B-cell non-Hodgkin's lymphoma